Tenon Medical Inc. (TNON)
Tenon Medical Statistics
Share Statistics
Tenon Medical has 3.14M shares outstanding. The number of shares has increased by 26.93% in one year.
Shares Outstanding | 3.14M |
Shares Change (YoY) | 26.93% |
Shares Change (QoQ) | 454.93% |
Owned by Institutions (%) | 39.39% |
Shares Floating | 3.14M |
Failed to Deliver (FTD) Shares | - |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 206.66K, so 6.59% of the outstanding shares have been sold short.
Short Interest | 206.66K |
Short % of Shares Out | 6.59% |
Short % of Float | 6.59% |
Short Ratio (days to cover) | 0.11 |
Valuation Ratios
The PE ratio is -0.18 and the forward PE ratio is -0.15. Tenon Medical's PEG ratio is 0.
PE Ratio | -0.18 |
Forward PE | -0.15 |
PS Ratio | 0.98 |
Forward PS | null |
PB Ratio | 3.68 |
P/FCF Ratio | -0.23 |
PEG Ratio | 0 |
Enterprise Valuation
Tenon Medical Inc. has an Enterprise Value (EV) of 2.3M.
EV / Earnings | -0.15 |
EV / Sales | 0.78 |
EV / EBITDA | -0.15 |
EV / EBIT | -0.15 |
EV / FCF | -0.18 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 2.39.
Current Ratio | 1.24 |
Quick Ratio | 1.06 |
Debt / Equity | 2.39 |
Total Debt / Capitalization | 70.47 |
Cash Flow / Debt | -6.56 |
Interest Coverage | -748.9 |
Financial Efficiency
Return on equity (ROE) is -20.03% and return on capital (ROIC) is -596.85%.
Return on Equity (ROE) | -20.03% |
Return on Assets (ROA) | -2.46% |
Return on Capital (ROIC) | -596.85% |
Revenue Per Employee | $139,428.57 |
Profits Per Employee | $-741,952.38 |
Employee Count | 21 |
Asset Turnover | 0.46 |
Inventory Turnover | 3.05 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.9, so Tenon Medical's price volatility has been higher than the market average.
Beta | 1.9 |
52-Week Price Change | null% |
50-Day Moving Average | 1.67 |
200-Day Moving Average | 3.69 |
Relative Strength Index (RSI) | 31.15 |
Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Tenon Medical had revenue of 2.93M and earned -15.58M in profits. Earnings per share was -68.71.
Revenue | 2.93M |
Gross Profit | 1.24M |
Operating Income | -15.73M |
Net Income | -15.58M |
EBITDA | -15.53M |
EBIT | -15.73M |
Earnings Per Share (EPS) | -68.71 |
Balance Sheet
The company has 2.43M in cash and 1.86M in debt, giving a net cash position of 571K.
Cash & Cash Equivalents | 2.43M |
Total Debt | 1.86M |
Net Cash | 571K |
Retained Earnings | -55.07M |
Total Assets | 13.04M |
Working Capital | 8.01M |
Cash Flow
In the last 12 months, operating cash flow was -12.18M and capital expenditures -361K, giving a free cash flow of -12.54M.
Operating Cash Flow | -12.18M |
Capital Expenditures | -361K |
Free Cash Flow | -12.54M |
FCF Per Share | -55.32 |
Margins
Gross margin is 42.38%, with operating and profit margins of -537.12% and -532.14%.
Gross Margin | 42.38% |
Operating Margin | -537.12% |
Pretax Margin | -532.14% |
Profit Margin | -532.14% |
EBITDA Margin | -530.33% |
EBIT Margin | -537.12% |
FCF Margin | -428.42% |
Dividends & Yields
TNON does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for TNON.
Price Target | $16 |
Price Target Difference | n/a |
Analyst Consensus | Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Sep 6, 2024. It was a backward split with a ratio of 1:8.
Last Split Date | Sep 6, 2024 |
Split Type | backward |
Split Ratio | 1:8 |
Scores
Altman Z-Score | -9 |
Piotroski F-Score | 3 |